Skip to content

XIENCE V 1009541-12Recalls & reported problems

Abbott Vascular Inc. · XIENCE V Everolimus Eluting Coronary Stent System 3.00 mm x 12 mm / Rapid-Exchange · Class 3 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648064074), received between Mar 1, 2018 and Mar 1, 2018 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Angina1
  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 1, 2018Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2013 ONE 4.0X15 MM XIENCE V STENT WAS IMPLANTED IN THE LEFT MAIN (LM) CORONARY ARTERY AND THE 3.0X12 MM XIENCE V STENT WAS IMPLANTED IN THE DISTAL LEFT CIRCUMFLEX (DLCX) CORONARY ARTERY. ON (B)(6) 2017 THE PATIENT HAD UNSTABLE ANGINA AND A 90% RESTENOSIS WAS FOUND IN THE DLCX ON THE CORONARY ANGIOGRAM. ON (B)(6) 2017 PERCUTANEOUS CORONARY INTERVENTION WAS PERFORMED IN THE DLCX. THE CONDITION RESOLVED. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

    Patient problems: Angina; Stenosis

    MAUDE report 7307876 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page